Healthcare provider profile · identity verified

Alexander J. Young, MD

Family Practice · ALBUQUERQUE, NM · NPI 1114967171

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	628	180
Levothyroxine Sodium	Levothyroxine Sodium	390	110
Lisinopril	Lisinopril	268	87
Losartan Potassium	Losartan Potassium	245	77
Gabapentin	Gabapentin	237	54
Amlodipine Besylate	Amlodipine Besylate	208	73
Tamsulosin Hcl	Tamsulosin Hcl	186	59
Omeprazole	Omeprazole	183	63
Rosuvastatin Calcium	Rosuvastatin Calcium	165	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	22
Famotidine	Famotidine	113	45
Trazodone Hcl	Trazodone Hcl	108	34
Escitalopram Oxalate	Escitalopram Oxalate	101	36
Hydrochlorothiazide	Hydrochlorothiazide	96	32
Metformin Hcl Er	Metformin Hcl	96	31
Metoprolol Succinate	Metoprolol Succinate	89	33
Mounjaro	Tirzepatide	87	17
Fluticasone Propionate	Fluticasone Propionate	84	38
Allopurinol	Allopurinol	79	23
Ozempic	Semaglutide	79	13
Simvastatin	Simvastatin	76	26
Carvedilol	Carvedilol	74	19
Albuterol Sulfate Hfa	Albuterol Sulfate	69	29
Pregabalin	Pregabalin	68	13
Metformin Hcl	Metformin Hcl	67	17
Eliquis	Apixaban	58	17
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	12
Alendronate Sodium	Alendronate Sodium	57	14
Potassium Chloride	Potassium Chloride	57	14
Tramadol Hcl	Tramadol Hcl	57	14
Duloxetine Hcl	Duloxetine Hcl	56	16
Furosemide	Furosemide	56	18
Bupropion Xl	Bupropion Hcl	53	20
Spironolactone	Spironolactone	52	18
Olmesartan Medoxomil	Olmesartan Medoxomil	49	17
Pantoprazole Sodium	Pantoprazole Sodium	49	17
Sertraline Hcl	Sertraline Hcl	49	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	12
Fluoxetine Hcl	Fluoxetine Hcl	47	13
Finasteride	Finasteride	46	15
Pravastatin Sodium	Pravastatin Sodium	45	14
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	44	13
Farxiga	Dapagliflozin Propanediol	43	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	14
Montelukast Sodium	Montelukast Sodium	42	17
Pioglitazone Hcl	Pioglitazone Hcl	42	11
Baclofen	Baclofen	40	15
Meloxicam	Meloxicam	40	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Citalopram Hbr	Citalopram Hydrobromide	38	14
Valsartan	Valsartan	38	15
Xarelto	Rivaroxaban	37	11
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Arnuity Ellipta	Fluticasone Furoate	33	15
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	12
Lorazepam	Lorazepam	31	suppressed
Prednisone	Prednisone	30	22
Azelastine Hcl	Azelastine Hcl	29	14
Chlorthalidone	Chlorthalidone	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Celecoxib	Celecoxib	24	13
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Myrbetriq	Mirabegron	22	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Atenolol	Atenolol	17	suppressed
Glipizide	Glipizide	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Cephalexin	Cephalexin	14	13
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Estradiol	Estradiol	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Nystop	Nystatin	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error